To our knowledge, these data are the first evidence for a specific interaction between a small molecule antagonist and the transmembrane domain of a peptide receptor.

Three types of atrial natriuretic peptide receptors have been identified on which natriuretic peptides act.

The receptor is called the gastrin-releasing peptide (GRP) receptor.

The peptide receptor may be bound to lutetium-177, yttrium-90 or indium-111.

In contrast to hormone-delivered radiotherapy, the lesions need not overexpress peptide receptors.

Other studies have shown that by targeting the gastrin-releasing peptide receptor pancreatic and breast cancer can be detected with PET imagining.

A atrial natriuretic peptide receptor is a receptor for atrial natriuretic peptide.

There are three distinct atrial natriuretic factor receptors identified so far in mammals: natriuretic peptide receptors 1, 2, and 3.

Even as she spoke, the peptide receptor fell away, uncoiling.

It binds to vasoactive intestinal peptide receptor and to the PACAP receptor.